我国医药电子商务发展现状及其对策研究

Research on the Current Situation and Countermeasures of China’s Pharmaceutical E-Commerce Development

摘要: 本文旨在系统梳理中国医药电子商务服务的发展进程，剖析其面临的深层次问题，并提出具有前瞻性的对策建议。研究发现，我国医药电商经历了从萌芽探索、政策规范到创新融合的演进历程，市场规模持续扩大，模式日趋多元，生态逐步构建。然而，其发展仍受制于政策法规的碎片化与滞后性、药品特殊性与线上服务局限的矛盾、供应链与末端履约能力瓶颈、“信息孤岛”现象与数据价值挖掘不足、以及行业人才结构性短缺等核心问题。未来，需通过健全法规标准体系、深化线上线下融合、创新技术赋能与监管、加强复合型人才培养及构建协同产业生态等多维路径，推动医药电商向更高质量、更有效率、更可持续的方向发展，从而更好地服务于“健康中国”战略。

Abstract: This article aims to systematically review the development process of China’s medical e-commerce services, analyze the deep-seated problems it faces, and propose forward-looking countermeasures and suggestions. The research finds that China’s medical e-commerce has undergone an evolutionary process from nascent exploration, policy regulation to innovative integration. The market scale has continued to expand, the models have become increasingly diverse, and the ecosystem has gradually been established. However, its development is still constrained by fragmented and lagging policies and regulations, the contradiction between the particularity of drugs and the limitations of online services, bottlenecks in the supply chain and last-mile delivery capabilities, the “information silo” phenomenon and insufficient data value mining, as well as structural shortages of industry talents. In the future, it is necessary to promote the development of medical e-commerce towards higher quality, greater efficiency and sustainability through multiple paths such as improving the legal and regulatory system, deepening the integration of online and offline, innovating technology empowerment and supervision, strengthening the cultivation of compound talents, and building a collaborative industrial ecosystem, so as to better serve the “Healthy China” strategy.